Bone morphogenetic proteins: facts, challenges, and future perspectives

Area of Science:

• Biochemistry
• Molecular Biology
• Regenerative Medicine

Background:

• Bone morphogenetic proteins (BMPs), part of the TGF-β superfamily, are crucial regulators of embryogenesis and skeletal tissue formation and repair.
• Advanced cell and molecular biology techniques, alongside transgenic animal studies, have elucidated the complex mechanisms governing BMP activity.
• Genetic engineering enables large-scale BMP production for clinical applications, often requiring controlled delivery systems like collagen or ceramics to enhance efficacy and prevent systemic diffusion.

Purpose of the Study:

• To review and discuss critical data concerning BMP structure, mechanisms of action, and potential clinical applications.
• To examine the benefits and drawbacks of using recombinant human BMPs (rhBMPs) in orthopedic and oral surgery.
• To highlight the need for rigorous clinical trials to confirm the safety and efficacy of rhBMPs, particularly in off-label uses.

Main Methods:

• Review of existing literature on BMPs, including cell and molecular biology studies, transgenic animal models, and clinical orthopedic trials.
• Analysis of data regarding the use of BMPs in conjunction with delivery systems for controlled release.
• Examination of reported side effects and off-label applications of rhBMPs.

Main Results:

• FDA-approved rhBMPs (2 and 7) have demonstrated benefits in orthopedic applications.
• Potential side effects associated with high-dose rhBMPs include swelling, seroma, and increased cancer risk.
• BMPs show promise in periodontal regeneration, sinus lifts, and non-union bone repair in oral surgery, though often used off-label.

Conclusions:

• Controlled delivery systems are essential for maximizing BMP biological activity at surgical sites.
• Despite demonstrated benefits, the clinical application of rhBMPs, especially off-label, requires more robust evidence from well-designed randomized controlled trials to establish safety and efficacy.
• Further research is needed to optimize BMP dosage and delivery to mitigate potential adverse effects while maximizing therapeutic benefits.